{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:48:40Z","timestamp":1761166120427,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.anndiagpath.2018.06.003","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T19:53:02Z","timestamp":1530129182000},"page":"28-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Subsequent breast and high grade serous carcinomas after risk-reducing salpingo-oophorectomy in BRCA mutation carriers and patients with history of breast cancer"],"prefix":"10.1016","volume":"36","author":[{"given":"Melissa M.","family":"Straub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirna B.","family":"Podoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie N.","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia L.","family":"Wiesner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed M.","family":"Desouki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.anndiagpath.2018.06.003_bb0005","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1016\/j.anndiagpath.2018.06.003_bb0010","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE","volume":"105","author":"Mavaddat","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.anndiagpath.2018.06.003_bb0015","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.anndiagpath.2018.06.003_bb0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.6004\/jnccn.2016.0018","article-title":"Genetic\/familial high-risk assessment: breast and ovarian, version 2.2015","volume":"14","author":"Daly","year":"2016","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.anndiagpath.2018.06.003_bb0025","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.gore.2015.03.007","article-title":"Low grade serious carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a \u201clow-grade serous tubal intra-epithelial carcinoma\u201d (STIC) on risk reducing surgery","volume":"12","author":"Chay","year":"2015","journal-title":"Gynecologic Oncology Reports"},{"issue":"15","key":"10.1016\/j.anndiagpath.2018.06.003_bb0030","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2018.06.003_bb0035","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/AOG.0b013e3181ec5fc1","article-title":"Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer","volume":"116","author":"Berek","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2018.06.003_bb0040","first-page":"480","article-title":"No. 344-opportunistic salpingectomy and other methods of risk reduction for ovarian\/fallopian tube\/peritoneal cancer in the general population","volume":"39","author":"Salvador","year":"2017","journal-title":"Journal of Obstetrics and Gynaecology Canada: JOGC\u202f=\u202fJournal d'Obstetrique et Gynecologie du Canada: JOGC"},{"issue":"4","key":"10.1016\/j.anndiagpath.2018.06.003_bb0045","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1634\/theoncologist.2016-0444","article-title":"Risk-reducing strategies for ovarian cancer in BRCA mutation carriers: a balancing act","volume":"22","author":"Tschernichovsky","year":"2017","journal-title":"Oncologist"},{"issue":"Pt A","key":"10.1016\/j.anndiagpath.2018.06.003_bb0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.steroids.2014.08.003","article-title":"Estrogen metabolites and breast cancer","volume":"99","author":"Santen","year":"2015","journal-title":"Steroids"},{"issue":"9","key":"10.1016\/j.anndiagpath.2018.06.003_bb0055","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/ijc.28537","article-title":"The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer\u2013a population-based data linkage study","volume":"134","author":"Obermair","year":"2014","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.anndiagpath.2018.06.003_bb0060","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1445-2197.2008.04614.x","article-title":"Laparoscopic oophorectomy in the management of breast disease","volume":"78","author":"Willsher","year":"2008","journal-title":"ANZ J Surg"},{"issue":"34","key":"10.1016\/j.anndiagpath.2018.06.003_bb0065","doi-asserted-by":"crossref","first-page":"8629","DOI":"10.1200\/JCO.2005.02.9199","article-title":"Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers","volume":"23","author":"Kramer","year":"2005","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2018.06.003_bb0070","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1089\/jwh.2013.4407","article-title":"Challenging and complex decisions in the management of the BRCA mutation carrier","volume":"22","author":"Stan","year":"2013","journal-title":"J Women's Health"},{"issue":"2","key":"10.1016\/j.anndiagpath.2018.06.003_bb0075","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2016.08.336","article-title":"Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers","volume":"143","author":"Zakhour","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"28","key":"10.1016\/j.anndiagpath.2018.06.003_bb0080","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1200\/JCO.2005.02.626","article-title":"Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer","volume":"23","author":"Madalinska","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913418301850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913418301850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:30:10Z","timestamp":1761078610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913418301850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":16,"alternative-id":["S1092913418301850"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2018.06.003","relation":{},"ISSN":["1092-9134"],"issn-type":[{"type":"print","value":"1092-9134"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subsequent breast and high grade serous carcinomas after risk-reducing salpingo-oophorectomy in BRCA mutation carriers and patients with history of breast cancer","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2018.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}